Form 4 Tracker
Katherine Stueland

Director, CHIEF EXECUTIVE OFFICER · 11 filings · Latest: Sep 16, 2026

GeneDx Holdings Corp.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
WGS
Katherine Stueland—Sep 9, 2024
Proposed Sale
$33.333,639$121.3K—

← Previous

Page 3 of 3